BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20797564)

  • 21. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating.
    Gobal F; Deshmukh A; Shah S; Mehta JL
    J Am Coll Cardiol; 2011 Jun; 57(23):2303-8. PubMed ID: 21636030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension.
    Seki S; Tsutsui K; Fujii T; Yamazaki K; Anzawa R; Yoshimura M
    Clin Exp Hypertens; 2010; 32(5):270-7. PubMed ID: 20662727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and mild to moderate chronic kidney disease among minorities.
    Navaneethan SD; Schold JD; Srinivas TR
    Semin Nephrol; 2010 Jan; 30(1):51-8. PubMed ID: 20116648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care.
    Lender D; Sysko SK
    Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolic syndrome in women.
    Schneider JG; Tompkins C; Blumenthal RS; Mora S
    Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrolithiasis as a systemic disorder.
    Sakhaee K
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):304-9. PubMed ID: 18408483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A; Mulhall JP
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology.
    Ren J; Kelley RO
    Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 2009 stock conference report: inflammation, obesity and metabolic disease.
    Hevener AL; Febbraio MA;
    Obes Rev; 2010 Sep; 11(9):635-44. PubMed ID: 20002885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and liver transplantation.
    Hanouneh IA; Zein NN
    Minerva Gastroenterol Dietol; 2010 Sep; 56(3):297-304. PubMed ID: 21037547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.